Marshall Wace, LLP Artivion, Inc. Transaction History

Marshall Wace, LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$19.62 - $25.65 $280,114 - $366,205	14,277 New	14,277 $366,000
Q1 2023 May 15, 2023	BUY	$11.74 - $14.12 $480,811 - $578,284	40,955 New	40,955 $536,000
Q2 2022 Aug 15, 2022	BUY	$15.73 - $22.91 $174,728 - $254,484	11,108 New	11,108 $210,000
Q1 2022 May 16, 2022	SELL	$16.95 - $21.74 $35,628 - $45,697	-2,102 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.19 - $22.84 $36,133 - $48,009	2,102 New	2,102 $43,000
Q1 2021 May 17, 2021	SELL	$22.07 - $26.31 $2.12 Million - $2.52 Million	-95,837 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.76 - $23.74 $1.01 Million - $1.43 Million	-60,144 Reduced 38.56%	95,837 $2.26 Million
Q3 2020 Nov 16, 2020	BUY	$16.35 - $21.4 $2.55 Million - $3.34 Million	155,981 New	155,981 $2.88 Million
Q4 2019 Feb 14, 2020	SELL	$22.45 - $27.09 $101,496 - $122,473	-4,521 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$25.98 - $30.8 $1.7 Million - $2.02 Million	-65,580 Reduced 93.55%	4,521 $123,000
Q2 2019 Aug 14, 2019	BUY	$27.55 - $32.39 $1.93 Million - $2.27 Million	70,101 New	70,101 $2.1 Million

175

35.9M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.08B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.